The role of cell types in cytomegalovirus infection in vivo

European Journal of Cell Biology

Volumn 91, Issue 1, 2012, Pages 70-77

  Sacher, Torsten ^a   Mohr, Christian A ^a   Weyn, Annelies ^a   Schlichting, Christina ^a   Koszinowski, Ulrich H ^a   Ruzsics, Zsolt ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell tropism; Conditional mutagenesis; Cre recombinase; Dissemination; Endothelial cells; Hepatocytes; Herpesvirus; Immune evasion; Immunogenicity; Pathogenesis; Transgenic mice; Viraemia

Indexed keywords

CRE RECOMBINASE;

ADAPTIVE IMMUNITY; CELL TYPE; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; SHORT SURVEY; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; HEPATOCYTES; HUMANS; IMMUNE EVASION; INTEGRASES; LUCIFERASES; MICE; MICE, TRANSGENIC; MUROMEGALOVIRUS; ORGAN SPECIFICITY; VIRAL LOAD; VIRAL PLAQUE ASSAY; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5; MAIZE CHLOROTIC MOTTLE VIRUS; MUS MUSCULUS;

EID: 84855942905     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.02.002     Document Type: Short Survey

References (30)

1. Adler S.P., Starr S.E., Plotkin S.A., Hempfling S.H., Buis J., Manning M.L., Best A.M. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J. Infect. Dis. 1995, 171:26-32.
2. Andrews D.M., Andoniou C.E., Granucci F., Ricciardi-Castagnoli P., Degli-Esposti M.A. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2001, 2:1077-1084.
3. Arrode G., Davrinche C. Dendritic cells and HCMV cross-presentation. Curr. Top. Microbiol. Immunol. 2003, 276:277-294.
4. Brune W., Menard C., Heesemann J., Koszinowski U.H. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 2001, 291:303-305.
5. Collins T.M., Quirk M.R., Jordan M.C. Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J. Virol. 1994, 68:6305-6311.
6. Constien R., Forde A., Liliensiek B., Grone H.J., Nawroth P., Hammerling G., Arnold B. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30:36-44.
7. DeFalco J., Tomishima M., Liu H., Zhao C., Cai X., Marth J.D., Enquist L., Friedman J.M. Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science 2001, 291:2608-2613.
8. Del Val M., Munch K., Reddehase M.J., Koszinowski U.H. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell 1989, 58:305-315.
9. Dymecki S.M., Tomasiewicz H. Using Flp-recombinase to characterize expansion of Wnt1-expressing neural progenitors in the mouse. Dev. Biol. 1998, 201:57-65.
10. Fenner F. Mouse-pox; infectious ectromelia of mice; a review. J. Immunol. 1949, 63:341-373.
11. Forde A., Constien R., Grone H.J., Hammerling G., Arnold B. Temporal Cre-mediated recombination exclusively in endothelial cells using Tie2 regulatory elements. Genesis 2002, 33:191-197.
12. Garlanda C., Dejana E. Heterogeneity of endothelial cells. Specific markers. Arterioscler. Thromb. Vasc. Biol. 1997, 17:1193-1202.
13. Hahn G., Revello M.G., Patrone M., Percivalle E., Campanini G., Sarasini A., Wagner M., Gallina A., Milanesi G., Koszinowski U., Baldanti F., Gerna G. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 2004, 78:10023-10033.
14. Hanson L.K., Slater J.S., Karabekian Z., Virgin H.W., Biron C.A., Ruzek M.C., van R.N., Ciavarra R.P., Stenberg R.M., Campbell A.E. Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J. Virol. 1999, 73:5970-5980.
15. Hengel H., Reusch U., Gutermann A., Ziegler H., Jonjic S., Lucin P., Koszinowski U.H. Cytomegaloviral control of MHC class I function in the mouse. Immunol. Rev. 1999, 168:167-176.
16. Hsu K.M., Pratt J.R., Akers W.J., Achilefu S.I., Yokoyama W.M. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J. Gen. Virol. 2009, 90:33-43.
17. Jonjic S., Babic M., Polic B., Krmpotic A. Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 2008, 20:30-38.
18. Jonjic S., Krmpotic A., Arapovic J., Koszinowski U.H. Dissection of the antiviral NK cell response by MCMV mutants. Methods Mol. Biol. 2008, 415:127-149.
19. Kern M., Popov A., Scholz K., Schumak B., Djandji D., Limmer A., Eggle D., Sacher T., Zawatzky R., Holtappels R., Reddehase M.J., Hartmann G., Debey-Pascher S., Diehl L., Kalinke U., Koszinowski U., Schultze J., Knolle P.A. Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology 2010, 138:336-346.
20. Lenac T., Arapovic J., Traven L., Krmpotic A., Jonjic S. Murine cytomegalovirus regulation of NKG2D ligands. Med. Microbiol. Immunol. 2008, 197:159-166.
21. Lewandoski M. Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2001, 2:743-755.
22. Mathys S., Schroeder T., Ellwart J., Koszinowski U.H., Messerle M., Just U. Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J. Infect. Dis. 2003, 187:988-999.
23. Menard C., Wagner M., Ruzsics Z., Holak K., Brune W., Campbell A.E., Koszinowski U.H. Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J. Virol. 2003, 77:5557-5570.
24. Mohr C.A., Arapovic J., Muhlbach H., Panzer M., Weyn A., Dolken L., Krmpotic A., Voehringer D., Ruzsics Z., Koszinowski U., Sacher T. A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination. J. Virol. 2010, 84:7730-7742.
25. Mohr C.A., Cicin-Sain L., Wagner M., Sacher T., Schnee M., Ruzsics Z., Koszinowski U.H. Engineering of cytomegalovirus genomes for recombinant live herpesvirus vaccines. Int. J. Med. Microbiol. 2008, 298:115-125.
26. Plachter B., Sinzger C., Jahn G. Cell types involved in replication and distribution of human cytomegalovirus. Adv. Virus Res. 1996, 46:195-261.
27. Sacher T., Podlech J., Mohr C.A., Jordan S., Ruzsics Z., Reddehase M.J., Koszinowski U.H. The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 2008, 3:263-272.
28. Vooijs M., van der Valk M., te Riele H., Berns A. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene 1998, 17:1-12.
29. Wagner M., Gutermann A., Podlech J., Reddehase M.J., Koszinowski U.H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 2002, 196:805-816.
30. Weller T.H. Pathogenesis of human cytomegalovirus-associated diseases. Historical perspective. Transplant. Proc. 1991, 23:5-6. (discussion).